Navigation Links
Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America
Date:9/2/2010

SAN DIEGO and OSAKA, Japan, Sept. 2 /PRNewswire-FirstCall/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) and Takeda Pharmaceutical Company Limited (TSE: 4502), today announced that they have entered into an exclusive partnership to develop and commercialize Contrave® (naltrexone SR/bupropion SR), Orexigen's investigational drug for the treatment of obesity, in the United States, Canada and Mexico.

Contrave is a combination therapy believed to address both biological and behavioral drivers of obesity. The central pathways targeted by this treatment are involved in controlling the balance of food intake and metabolism, and regulating reward-based eating behavior.  Orexigen submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Contrave on March 31, 2010 and the Prescription Drug User Fee Act (PDUFA) action date has been set for January 31, 2011.

Under the terms of the agreement, Orexigen will receive an upfront cash payment of $50 million from Takeda, and Takeda will obtain an exclusive marketing right from Orexigen in the United States, Mexico and Canada while Orexigen retains the right to co-promote with Takeda in the United States. Orexigen will be eligible to receive payments of over $1 billion upon achieving certain regulatory and sales-based milestones. Assuming Contrave is commercialized, Takeda will pay tiered double-digit royalty payments on net sales in the Territory.

Under the terms of the agreement, Orexigen and Takeda will work together on ongoing development of the product, with Orexigen leading pre-approval activities, and Takeda leading post-approval activities.  The parties will share in the costs of any future development of the product.

"Takeda is an ideal partner for Contrave given its proven track record in commercializing innovative medicines and its commitment to the treatment of
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Orexigen® Therapeutics COR-BMOD Study Published in the Journal Obesity
2. Orexigen® Therapeutics Announces Publication of COR-I Phase 3 Study of Contrave in Lancet
3. Orexigen® Therapeutics Schedules August 5, 2010 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2010
4. Orexigen® Therapeutics Announces FDA Acceptance of Contrave® New Drug Application for the Treatment of Obesity
5. Reportlinker Adds Urological Disorders Therapeutics to 2016 - Increasing Awareness and Aging Population will Drive the Benign Prostatic Hyperplasia and Urinary Incontinence Markets
6. Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
7. Echo Therapeutics Announces Successful Completion of Clinical Trial for Prelude™ SkinPrep System and 4% Lidocaine Cream
8. BioMarin Acquires ZyStor Therapeutics, Inc.
9. Nile Therapeutics Reports 2010 Second Quarter Financial Results
10. Cornerstone Therapeutics Announces Development of Generic for Tussionex®
11. Cornerstone Therapeutics Licenses Alpha-7 Technology to Targacept
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015 Doctors from ... at Children,s National Health System are ... to treat osteoid osteoma, a benign but painful ... adults, using an experimental magnetic resonance-guided high-intensity focused ultrasound ... and 10-year-old Niyati Shah , have been treated ...
(Date:5/27/2015)... -- The report " Tube Packaging Market  by Type ... Food & beverages, Pharmaceuticals, Consumer Goods), by Material Type (Laminated ... & Forecasts to 2020", published by MarketsandMarkets, The global market ... of 6.65% from 2015, to reach $8,638.9 Million by 2020. ...   61 F igures spread thro ugh 241 ...
(Date:5/27/2015)... May 27, 2015  Vital Access Corp. announced today ... facility with Deerfield Management, a healthcare investment firm. Proceeds ... Access, continued global expansion of its innovative VWING™ Vascular ... Company,s proprietary vascular access platform. "Vital Access ... partner. Deerfield is a healthcare investor with great depth ...
Breaking Medicine Technology:Children's National first in US to destroy bone tumors with incisionless surgery 2Children's National first in US to destroy bone tumors with incisionless surgery 3Children's National first in US to destroy bone tumors with incisionless surgery 4Tube Packaging Market Worth $8.63 Billion by 2020 2Tube Packaging Market Worth $8.63 Billion by 2020 3Tube Packaging Market Worth $8.63 Billion by 2020 4Vital Access Receives $10 Million Financing Commitment from Deerfield 2Vital Access Receives $10 Million Financing Commitment from Deerfield 3
... Jan. 31, 2012 BioRestorative Therapies, Inc. (OTCQB: BRTX ... License Agreement with Regenerative Sciences, LLC ("RS") with respect to ... RS. The treatment is an advanced stem cell injection procedure ... leg pain, or numbness and tingling in the legs or ...
... Jan. 31, 2012  For the first time, an ... the best practices for performing Laparoscopic Sleeve Gastrectomy, ... (Logo:  http://photos.prnewswire.com/prnh/20110513/NY01718LOGO ) The ... compiled the consensus statement to help the surgical ...
Cached Medicine Technology:BioRestorative Therapies Signs License Agreement for Stem Cell Disc/Spine Procedure 2BioRestorative Therapies Signs License Agreement for Stem Cell Disc/Spine Procedure 3International Panel of Leading Bariatric Surgeons Reaches Consensus on Optimal Techniques for Laparoscopic Sleeve Gastrectomy 2
(Date:5/27/2015)... Thermage was the first to come out with ... 2007 coinciding with the release of NXT or CPT, the ... Aesthetics was the first practice in New York to debut ... results that had never been achieved before non-surgically. Even ... considered by many as the leading skin tightening device. ...
(Date:5/27/2015)... 2015 Western University of Health Sciences’ ... historic firsts -- and one profound last. , The ... marked the first time the university surpassed more than ... Graduate College of Biomedical Sciences (GCBS) alumnus graduated from ... , The university’s fifth and final ceremony of its ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 The BBB ... customer service practices that enhance customer trust and confidence ... Standards for Trust, eight principles that summarize important elements ... also represents standards for business accreditation by BBB. Businesses ... these standards and complete application procedures will be accredited ...
(Date:5/27/2015)... Arizona (PRWEB) May 27, 2015 Continuing ... mission of healthier patients in the community, SmartPractice® ... Center (formerly John C. Lincoln). SmartPractice Vice President of ... Michelle Shaw presented a $25,000 check to Paulla Miller, ... HonorHealth’s Breast Health & Research Center on April 30. ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 Allred Dental located ... help patients - who need extensive dental treatment - understand ... treatment options customized for their problems. , Dr. Jeff Allred ... visual presentation of the assessment of the patient’s oral health ... which can treat their oral health problems. , “The dental ...
Breaking Medicine News(10 mins):Health News:Non-Surgical Fat Reduction and Skin Tightening Procedures, Thermage and Exilis, Increase 200% at Precision Aesthetics in New York, April 2015 2Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 2Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 3Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 4Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 5Health News:Carson Energy Receives A+ Accredited Rating For 19 Consecutive Years 2Health News:SmartPractice Donates $25,000 to HonorHealth Breast Health and Research Center 2Health News:San Marcos Dentistry Office Offering a New Service Dental Case Planning 2
... By Kathleen Doheny HealthDay Reporter , ... in higher-income homes without a biological father are likely ... finds. "In higher-income families, father absence predicted earlier ... said study leader Julianna Deardorff. "Girls in upper-income ...
... impacts everyday living in many ways, the latest technologies ... potential to help older adults live better for longer. ... Aging,s third annual "UCLA Technology and Aging Conference: Science ... who will explore cutting-edge innovations affecting every aspect of ...
... and maternal deaths will fail to extend gains unless world ... families and communities, according to a new World Vision report ... through family care" examines how the resources invested to achieve ... toward saving the more than 8 million children under the ...
... HealthDay Reporter , FRIDAY, Sept. 17 (HealthDay News) ... risks to their children. They lock up household cleaners and ... youngsters. But health experts believe the most prevalent poisoning ... in the garage -- but in the medicine cabinet. ...
... public health problems in developed countries", Juan P. Rey-Lpez, lead ... of Zaragoza (UNIZAR), tells SINC. "During the week, one-third of ... per day. At weekends, this figure exceeds 60%". ... Preventive Medicine , show that teenagers devote more time ...
... By Madonna Behen HealthDay Reporter , THURSDAY, Sept. ... are much better at turning their thoughts inward and reflecting ... come down partly to differences in brain structure. ... Science , researchers report that people who are ...
Cached Medicine News:Health News:Absent Father Might Mean Earlier Puberty for Higher-Income Girls 2Health News:Absent Father Might Mean Earlier Puberty for Higher-Income Girls 3Health News:UCLA conference to address technology's impact on successful aging Oct. 29 2Health News:UCLA conference to address technology's impact on successful aging Oct. 29 3Health News:UCLA conference to address technology's impact on successful aging Oct. 29 4Health News:UCLA conference to address technology's impact on successful aging Oct. 29 5Health News:Progress against child deaths will lag until family, community care prioritized 2Health News:Medicines Pose Greater Threat to Kids Than Chemicals 2Health News:Medicines Pose Greater Threat to Kids Than Chemicals 3Health News:Medicines Pose Greater Threat to Kids Than Chemicals 4Health News:Teenagers are more sedentary on weekends 2Health News:Feeling Introspective? Your Brain Structure May Be Key 2Health News:Feeling Introspective? Your Brain Structure May Be Key 3
... breadth of infectious disease ELISA products make ... standard assay protocols for faster integration into ... products provide increased reliability and run-to-run consistency. ... detection assays for a wide range of ...
... ELISA products make us a leader in ... faster integration into the busy laboratory, our ... and run-to-run consistency. Our Infectious Disease ELISA ... wide range of serological assays including ToRCH, ...
... Our breadth of infectious disease ELISA ... field. With standard assay protocols for faster ... Disease ELISA products provide increased reliability and ... includes antibody detection assays for a wide ...
... DIFF CHEK-30 is a rapid ELISA ... 100% negative predictive value and 99% sensitivity. ... and cost-effectively screen out C. difficile negatives ... of samples - before culturing for the ...
Medicine Products: